RDM1 and neoplasm: Additionally, the use of AK4 LUAD tumor gene signatures is associated with the oncogenic protein RAD52 motif Containing 1 (RDM1) at the LUAD tumor stage 2–3 and 3–4 interfaces (Figure 5C).